Ontology type: schema:ScholarlyArticle Open Access: True
1995-03
AUTHORSGordon L. Amidon, Hans Lennernäs, Vinod P. Shah, John R. Crison
ABSTRACTA biopharmaceutics drug classification scheme for correlating in vitro drug product dissolution and in vivo bioavailability is proposed based on recognizing that drug dissolution and gastrointestinal permeability are the fundamental parameters controlling rate and extent of drug absorption. This analysis uses a transport model and human permeability results for estimating invivo drug absorption to illustrate the primary importance of solubility and permeability on drug absorption. The fundamental parameters which define oral drug absorption in humans resulting from this analysis are discussed and used as a basis for this classification scheme. These Biopharmaceutic Drug Classes are defined as: Case 1. High solubility-high permeability drugs, Case 2. Low solubility-high permeability drugs, Case 3. High solubility-low permeability drugs, and Case 4. Low solubility-low permeability drugs. Based on this classification scheme, suggestions are made for setting standards for in vitro drug dissolution testing methodology which will correlate with the in vivo process. This methodology must be based on the physiological and physical chemical properties controlling drug absorption. This analysis points out conditions under which noin vitro-in vivo correlation may be expected e.g. rapidly dissolving low permeability drugs. Furthermore, it is suggested for example that for very rapidly dissolving high solubility drugs, e.g. 85% dissolution in less than 15 minutes, a simple one point dissolution test, is all that may be needed to insure bioavailability. For slowly dissolving drugs a dissolution profile is required with multiple time points in systems which would include low pH, physiological pH, and surfactants and the in vitro conditions should mimic the in vivo processes. This classification scheme provides a basis for establishing in vitro-in vivo correlations and for estimating the absorption of drugs based on the fundamental dissolution and permeability properties of physiologic importance. More... »
PAGES413-420
http://scigraph.springernature.com/pub.10.1023/a:1016212804288
DOIhttp://dx.doi.org/10.1023/a:1016212804288
DIMENSIONShttps://app.dimensions.ai/details/publication/pub.1037126380
PUBMEDhttps://www.ncbi.nlm.nih.gov/pubmed/7617530
JSON-LD is the canonical representation for SciGraph data.
TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT
[
{
"@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json",
"about": [
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Medical and Health Sciences",
"type": "DefinedTerm"
},
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1115",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Pharmacology and Pharmaceutical Sciences",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Biological Availability",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Cimetidine",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Gastric Emptying",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "In Vitro Techniques",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Jejunum",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Mathematics",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Models, Theoretical",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Permeability",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Pharmaceutical Preparations",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Piroxicam",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Solubility",
"type": "DefinedTerm"
}
],
"author": [
{
"affiliation": {
"alternateName": "College of Pharmacy, The University of Michigan, 48109-1065, Ann Arbor, Michigan",
"id": "http://www.grid.ac/institutes/grid.214458.e",
"name": [
"College of Pharmacy, The University of Michigan, 48109-1065, Ann Arbor, Michigan"
],
"type": "Organization"
},
"familyName": "Amidon",
"givenName": "Gordon L.",
"id": "sg:person.014127067437.90",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014127067437.90"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "School of Pharmacy, Uppsala University, Box 580, S-751 23, Uppsala, Sweden",
"id": "http://www.grid.ac/institutes/grid.8993.b",
"name": [
"School of Pharmacy, Uppsala University, Box 580, S-751 23, Uppsala, Sweden"
],
"type": "Organization"
},
"familyName": "Lennern\u00e4s",
"givenName": "Hans",
"id": "sg:person.01372131203.73",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01372131203.73"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "PDA, HFD-602, 20857, Rockville, Maryland",
"id": "http://www.grid.ac/institutes/grid.479064.8",
"name": [
"PDA, HFD-602, 20857, Rockville, Maryland"
],
"type": "Organization"
},
"familyName": "Shah",
"givenName": "Vinod P.",
"id": "sg:person.01223074603.31",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01223074603.31"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "TSRL, Inc., 540 Avis Drive, Suite A, 48108, Ann Arbor, Michigan",
"id": "http://www.grid.ac/institutes/grid.281449.2",
"name": [
"TSRL, Inc., 540 Avis Drive, Suite A, 48108, Ann Arbor, Michigan"
],
"type": "Organization"
},
"familyName": "Crison",
"givenName": "John R.",
"id": "sg:person.015752121734.07",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015752121734.07"
],
"type": "Person"
}
],
"citation": [
{
"id": "sg:pub.10.1007/bf00562664",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1044388678",
"https://doi.org/10.1007/bf00562664"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1023/a:1015909716312",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1038769588",
"https://doi.org/10.1023/a:1015909716312"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1023/a:1015829128646",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1047482208",
"https://doi.org/10.1023/a:1015829128646"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1023/a:1015888813741",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1040826363",
"https://doi.org/10.1023/a:1015888813741"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1023/a:1015927004752",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1042556047",
"https://doi.org/10.1023/a:1015927004752"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1023/a:1018947113238",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1051994422",
"https://doi.org/10.1023/a:1018947113238"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/bf01061761",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1036555799",
"https://doi.org/10.1007/bf01061761"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1023/a:1015892621261",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1035241234",
"https://doi.org/10.1023/a:1015892621261"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1023/a:1018999130076",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1002102293",
"https://doi.org/10.1023/a:1018999130076"
],
"type": "CreativeWork"
}
],
"datePublished": "1995-03",
"datePublishedReg": "1995-03-01",
"description": "A biopharmaceutics drug classification scheme for correlating in vitro drug product dissolution and in vivo bioavailability is proposed based on recognizing that drug dissolution and gastrointestinal permeability are the fundamental parameters controlling rate and extent of drug absorption. This analysis uses a transport model and human permeability results for estimating invivo drug absorption to illustrate the primary importance of solubility and permeability on drug absorption. The fundamental parameters which define oral drug absorption in humans resulting from this analysis are discussed and used as a basis for this classification scheme. These Biopharmaceutic Drug Classes are defined as: Case 1. High solubility-high permeability drugs, Case 2. Low solubility-high permeability drugs, Case 3. High solubility-low permeability drugs, and Case 4. Low solubility-low permeability drugs. Based on this classification scheme, suggestions are made for setting standards for in vitro drug dissolution testing methodology which will correlate with the in vivo process. This methodology must be based on the physiological and physical chemical properties controlling drug absorption. This analysis points out conditions under which noin vitro-in vivo correlation may be expected e.g. rapidly dissolving low permeability drugs. Furthermore, it is suggested for example that for very rapidly dissolving high solubility drugs, e.g. 85% dissolution in less than 15 minutes, a simple one point dissolution test, is all that may be needed to insure bioavailability. For slowly dissolving drugs a dissolution profile is required with multiple time points in systems which would include low pH, physiological pH, and surfactants and the in vitro conditions should mimic the in vivo processes. This classification scheme provides a basis for establishing in vitro-in vivo correlations and for estimating the absorption of drugs based on the fundamental dissolution and permeability properties of physiologic importance.",
"genre": "article",
"id": "sg:pub.10.1023/a:1016212804288",
"isAccessibleForFree": true,
"isFundedItemOf": [
{
"id": "sg:grant.2508276",
"type": "MonetaryGrant"
},
{
"id": "sg:grant.2511825",
"type": "MonetaryGrant"
}
],
"isPartOf": [
{
"id": "sg:journal.1094644",
"issn": [
"0724-8741",
"1573-904X"
],
"name": "Pharmaceutical Research",
"publisher": "Springer Nature",
"type": "Periodical"
},
{
"issueNumber": "3",
"type": "PublicationIssue"
},
{
"type": "PublicationVolume",
"volumeNumber": "12"
}
],
"keywords": [
"drug product dissolution",
"vivo bioavailability",
"drug absorption",
"product dissolution",
"high-solubility drugs",
"physical-chemical properties",
"vivo correlation",
"Biopharmaceutic Drug Classification",
"drug dissolution",
"dissolution profiles",
"oral drug absorption",
"low-permeability drugs",
"dissolution test",
"physiological pH",
"chemical properties",
"absorption of drugs",
"drug classification scheme",
"dissolution",
"vivo processes",
"low pH",
"bioavailability",
"absorption",
"pH",
"permeability properties",
"surfactants",
"properties",
"solubility",
"permeability results",
"fundamental dissolution",
"fundamental parameters",
"drugs",
"transport model",
"permeability",
"Noin",
"gastrointestinal permeability",
"process",
"primary importance",
"conditions",
"basis",
"analysis",
"parameters",
"drug classification",
"methodology",
"class",
"drug classes",
"correlation",
"importance",
"theoretical basis",
"profile",
"system",
"example",
"rate",
"results",
"extent",
"standards",
"point",
"physiologic importance",
"minutes",
"test",
"scheme",
"testing methodology",
"model",
"classification scheme",
"humans",
"suggestions",
"multiple time points",
"Case 2",
"Case 1",
"time points",
"Case 3",
"Case 4",
"classification"
],
"name": "A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of in Vitro Drug Product Dissolution and in Vivo Bioavailability",
"pagination": "413-420",
"productId": [
{
"name": "dimensions_id",
"type": "PropertyValue",
"value": [
"pub.1037126380"
]
},
{
"name": "doi",
"type": "PropertyValue",
"value": [
"10.1023/a:1016212804288"
]
},
{
"name": "pubmed_id",
"type": "PropertyValue",
"value": [
"7617530"
]
}
],
"sameAs": [
"https://doi.org/10.1023/a:1016212804288",
"https://app.dimensions.ai/details/publication/pub.1037126380"
],
"sdDataset": "articles",
"sdDatePublished": "2022-08-04T16:52",
"sdLicense": "https://scigraph.springernature.com/explorer/license/",
"sdPublisher": {
"name": "Springer Nature - SN SciGraph project",
"type": "Organization"
},
"sdSource": "s3://com-springernature-scigraph/baseset/20220804/entities/gbq_results/article/article_306.jsonl",
"type": "ScholarlyArticle",
"url": "https://doi.org/10.1023/a:1016212804288"
}
]Download the RDF metadata as: json-ld nt turtle xml License info
JSON-LD is a popular format for linked data which is fully compatible with JSON.
curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1023/a:1016212804288'
N-Triples is a line-based linked data format ideal for batch operations.
curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1023/a:1016212804288'
Turtle is a human-readable linked data format.
curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1023/a:1016212804288'
RDF/XML is a standard XML format for linked data.
curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1023/a:1016212804288'
This table displays all metadata directly associated to this object as RDF triples.
247 TRIPLES
21 PREDICATES
118 URIs
101 LITERALS
18 BLANK NODES